vs

Side-by-side financial comparison of DILLARD'S, INC. (DDS) and Zebra Technologies (ZBRA). Click either name above to swap in a different company.

Zebra Technologies is the larger business by last-quarter revenue ($1.5B vs $1.5B, roughly 1.0× DILLARD'S, INC.). DILLARD'S, INC. runs the higher net margin — 8.8% vs 4.7%, a 4.1% gap on every dollar of revenue. On growth, Zebra Technologies posted the faster year-over-year revenue change (10.6% vs 2.9%). Zebra Technologies produced more free cash flow last quarter ($327.0M vs $156.2M). Over the past eight quarters, Zebra Technologies's revenue compounded faster (12.0% CAGR vs -16.9%).

Dillard's, Inc. is an American department store chain founded in 1938 by William T. Dillard. It is headquartered in Little Rock, Arkansas, and operates approximately 272 stores in 30 states. Currently, the largest number of stores are located in Texas with 57 and Florida with 42.

Zebra Technologies Corporation (ZBR), commonly known as Zebra, is an American multinational technology conglomerate corporation specializing in smart data capture systems. Zebra is headquartered in Lincolnshire, Illinois outside of Chicago with 10,700 employees across 57 countries.

DDS vs ZBRA — Head-to-Head

Bigger by revenue
ZBRA
ZBRA
1.0× larger
ZBRA
$1.5B
$1.5B
DDS
Growing faster (revenue YoY)
ZBRA
ZBRA
+7.6% gap
ZBRA
10.6%
2.9%
DDS
Higher net margin
DDS
DDS
4.1% more per $
DDS
8.8%
4.7%
ZBRA
More free cash flow
ZBRA
ZBRA
$170.8M more FCF
ZBRA
$327.0M
$156.2M
DDS
Faster 2-yr revenue CAGR
ZBRA
ZBRA
Annualised
ZBRA
12.0%
-16.9%
DDS

Income Statement — Q3 FY2026 vs Q4 FY2025

Metric
DDS
DDS
ZBRA
ZBRA
Revenue
$1.5B
$1.5B
Net Profit
$129.8M
$70.0M
Gross Margin
43.4%
47.3%
Operating Margin
11.5%
9.4%
Net Margin
8.8%
4.7%
Revenue YoY
2.9%
10.6%
Net Profit YoY
4.2%
-57.1%
EPS (diluted)
$8.31
$1.40

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
DDS
DDS
ZBRA
ZBRA
Q4 25
$1.5B
$1.5B
Q3 25
$1.5B
$1.3B
Q2 25
$1.5B
$1.3B
Q1 25
$2.0B
$1.3B
Q4 24
$1.4B
$1.3B
Q3 24
$1.5B
$1.3B
Q2 24
$1.5B
$1.2B
Q1 24
$2.1B
$1.2B
Net Profit
DDS
DDS
ZBRA
ZBRA
Q4 25
$129.8M
$70.0M
Q3 25
$72.8M
$101.0M
Q2 25
$163.8M
$112.0M
Q1 25
$214.4M
$136.0M
Q4 24
$124.6M
$163.0M
Q3 24
$74.5M
$137.0M
Q2 24
$180.0M
$113.0M
Q1 24
$250.5M
$115.0M
Gross Margin
DDS
DDS
ZBRA
ZBRA
Q4 25
43.4%
47.3%
Q3 25
36.6%
48.0%
Q2 25
43.9%
47.6%
Q1 25
34.9%
49.3%
Q4 24
42.6%
48.6%
Q3 24
37.6%
48.8%
Q2 24
44.6%
48.4%
Q1 24
36.6%
47.9%
Operating Margin
DDS
DDS
ZBRA
ZBRA
Q4 25
11.5%
9.4%
Q3 25
6.2%
13.9%
Q2 25
14.0%
14.2%
Q1 25
11.7%
14.9%
Q4 24
11.4%
16.9%
Q3 24
6.5%
15.2%
Q2 24
15.2%
13.7%
Q1 24
13.3%
13.5%
Net Margin
DDS
DDS
ZBRA
ZBRA
Q4 25
8.8%
4.7%
Q3 25
4.8%
7.7%
Q2 25
10.7%
8.7%
Q1 25
10.6%
10.4%
Q4 24
8.7%
12.2%
Q3 24
5.0%
10.9%
Q2 24
11.6%
9.3%
Q1 24
11.8%
9.8%
EPS (diluted)
DDS
DDS
ZBRA
ZBRA
Q4 25
$8.31
$1.40
Q3 25
$4.66
$1.97
Q2 25
$10.39
$2.19
Q1 25
$13.41
$2.62
Q4 24
$7.73
$3.14
Q3 24
$4.59
$2.64
Q2 24
$11.09
$2.17
Q1 24
$15.41
$2.23

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
DDS
DDS
ZBRA
ZBRA
Cash + ST InvestmentsLiquidity on hand
$1.1B
$125.0M
Total DebtLower is stronger
Stockholders' EquityBook value
$2.0B
$3.6B
Total Assets
$4.3B
$8.5B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
DDS
DDS
ZBRA
ZBRA
Q4 25
$1.1B
$125.0M
Q3 25
$1.0B
$1.1B
Q2 25
$900.5M
$872.0M
Q1 25
$717.9M
$879.0M
Q4 24
$980.4M
$901.0M
Q3 24
$946.7M
$676.0M
Q2 24
$817.8M
$411.0M
Q1 24
$808.3M
$127.0M
Total Debt
DDS
DDS
ZBRA
ZBRA
Q4 25
Q3 25
$2.2B
Q2 25
$2.2B
Q1 25
$2.2B
Q4 24
Q3 24
$2.2B
Q2 24
$2.2B
Q1 24
$2.1B
Stockholders' Equity
DDS
DDS
ZBRA
ZBRA
Q4 25
$2.0B
$3.6B
Q3 25
$1.9B
$3.7B
Q2 25
$1.9B
$3.6B
Q1 25
$1.8B
$3.6B
Q4 24
$2.0B
$3.6B
Q3 24
$1.9B
$3.4B
Q2 24
$1.9B
$3.3B
Q1 24
$1.7B
$3.2B
Total Assets
DDS
DDS
ZBRA
ZBRA
Q4 25
$4.3B
$8.5B
Q3 25
$3.7B
$8.1B
Q2 25
$3.9B
$7.9B
Q1 25
$3.5B
$7.9B
Q4 24
$4.1B
$8.0B
Q3 24
$3.7B
$7.7B
Q2 24
$3.9B
$7.5B
Q1 24
$3.4B
$7.3B
Debt / Equity
DDS
DDS
ZBRA
ZBRA
Q4 25
Q3 25
0.58×
Q2 25
0.60×
Q1 25
0.60×
Q4 24
Q3 24
0.64×
Q2 24
0.66×
Q1 24
0.66×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
DDS
DDS
ZBRA
ZBRA
Operating Cash FlowLast quarter
$186.5M
$357.0M
Free Cash FlowOCF − Capex
$156.2M
$327.0M
FCF MarginFCF / Revenue
10.6%
22.2%
Capex IntensityCapex / Revenue
2.1%
2.0%
Cash ConversionOCF / Net Profit
1.44×
5.10×
TTM Free Cash FlowTrailing 4 quarters
$781.3M
$831.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
DDS
DDS
ZBRA
ZBRA
Q4 25
$186.5M
$357.0M
Q3 25
$86.8M
$235.0M
Q2 25
$232.6M
$147.0M
Q1 25
$364.7M
$178.0M
Q4 24
$173.5M
$306.0M
Q3 24
$-68.4M
$294.0M
Q2 24
$244.4M
$288.0M
Q1 24
$436.5M
$125.0M
Free Cash Flow
DDS
DDS
ZBRA
ZBRA
Q4 25
$156.2M
$327.0M
Q3 25
$60.1M
$216.0M
Q2 25
$215.8M
$130.0M
Q1 25
$349.3M
$158.0M
Q4 24
$145.4M
$288.0M
Q3 24
$-94.3M
$277.0M
Q2 24
$209.2M
$278.0M
Q1 24
$408.2M
$111.0M
FCF Margin
DDS
DDS
ZBRA
ZBRA
Q4 25
10.6%
22.2%
Q3 25
4.0%
16.4%
Q2 25
14.1%
10.1%
Q1 25
17.3%
12.1%
Q4 24
10.2%
21.6%
Q3 24
-6.3%
22.1%
Q2 24
13.5%
22.8%
Q1 24
19.2%
9.4%
Capex Intensity
DDS
DDS
ZBRA
ZBRA
Q4 25
2.1%
2.0%
Q3 25
1.8%
1.4%
Q2 25
1.1%
1.3%
Q1 25
0.8%
1.5%
Q4 24
2.0%
1.3%
Q3 24
1.7%
1.4%
Q2 24
2.3%
0.8%
Q1 24
1.3%
1.2%
Cash Conversion
DDS
DDS
ZBRA
ZBRA
Q4 25
1.44×
5.10×
Q3 25
1.19×
2.33×
Q2 25
1.42×
1.31×
Q1 25
1.70×
1.31×
Q4 24
1.39×
1.88×
Q3 24
-0.92×
2.15×
Q2 24
1.36×
2.55×
Q1 24
1.74×
1.09×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

DDS
DDS

Segment breakdown not available.

ZBRA
ZBRA

Tangible Products$1.2B83%
Service And Software$255.0M17%

Related Comparisons